Yimin Cui

IUPHAR ECR review: The cGAS-STING pathway: novel functions beyond innate immune and emerging therapeutic opportunities.

Xu He, Y. Gu, Juqi Zhang, 2024, Pharmacological research.

Platelet factor 4(PF4) and its multiple roles in diseases.

Q. Xiang, Hanxu Zhang, Zhiyan Liu, 2023, Blood reviews.

Effects of PCSK9 on thrombosis and haemostasis in a variety of metabolic states: Lipids and beyond (Review)

Q. Xiang, Guangyan Mu, Yimin Cui, 2024, International journal of molecular medicine.

The Pharmacogenetic Variability Associated With the Pharmacokinetics and Pharmacodynamics of Rivaroxaban in Healthy Chinese Subjects: A National Multicenter Exploratory Study.

Q. Xiang, Xia Zhao, Hanxu Zhang, 2024, Clinical therapeutics.

Bayesian network analysis of risk classification strategies in the regulation of cellular products.

Yimin Cui, Guoshu Jia, Lixia Fu, 2024, Artificial intelligence in medicine.

C-type lectin-like receptor 2: roles and drug target

Q. Xiang, Zhiyan Liu, Zhe Wang, 2024, Thrombosis journal.

Abemaciclib increases the risk of venous thromboembolism in breast cancer: Integrate meta-analysis, pharmacovigilance database analysis, and in vitro validation.

Q. Xiang, Qianxin Liu, Manqi Hua, 2024, Cancer treatment reviews.